ES2093774T3 - Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. - Google Patents

Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.

Info

Publication number
ES2093774T3
ES2093774T3 ES92302016T ES92302016T ES2093774T3 ES 2093774 T3 ES2093774 T3 ES 2093774T3 ES 92302016 T ES92302016 T ES 92302016T ES 92302016 T ES92302016 T ES 92302016T ES 2093774 T3 ES2093774 T3 ES 2093774T3
Authority
ES
Spain
Prior art keywords
compound
cetoprostaglandina
stimulation
wound healing
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92302016T
Other languages
English (en)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13554827&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2093774(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2093774T3 publication Critical patent/ES2093774T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN USO DE UN COMPUESTO DE 15-CETO-PROSTAGLANDINA PARA LA PRODUCCION DE UN MEDICAMENTO PARA ESTIMULAR LA CICATRIZACION DE HERIDAS.
ES92302016T 1991-03-14 1992-03-10 Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina. Expired - Lifetime ES2093774T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7470291 1991-03-14

Publications (1)

Publication Number Publication Date
ES2093774T3 true ES2093774T3 (es) 1997-01-01

Family

ID=13554827

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92302016T Expired - Lifetime ES2093774T3 (es) 1991-03-14 1992-03-10 Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.

Country Status (12)

Country Link
US (1) US5252605A (es)
EP (1) EP0503887B1 (es)
JP (1) JP2515458B2 (es)
KR (1) KR100221370B1 (es)
AT (1) ATE141794T1 (es)
AU (1) AU648877B2 (es)
CA (1) CA2062653C (es)
DE (1) DE69213057T2 (es)
DK (1) DK0503887T3 (es)
ES (1) ES2093774T3 (es)
GR (1) GR3021117T3 (es)
NZ (1) NZ241940A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015739A1 (fr) * 1992-02-07 1993-08-19 Kaken Pharmaceutical Co., Ltd. Remede destine aux blessures ou aux hemorroides
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
ES2182088T3 (es) 1996-06-10 2003-03-01 Sucampo Ag Antagonista de la endotelina.
ATE401894T1 (de) * 1997-11-28 2008-08-15 Sucampo Ag Verwendung von 15-keto-prostaglandin-e verbindungen als endothelin antagonisten
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
AU2002307725B2 (en) * 2001-05-18 2008-07-10 Sucampo Ag Cathartic composition
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
EP1535617A1 (en) * 2002-07-02 2005-06-01 Wakamoto Pharmaceutical Co., Ltd. Remedy or preventive for keratoconjunctival epithelial cell injury
US20050124699A1 (en) * 2002-07-02 2005-06-09 Wakamoto Pharmaceutical Co., Ltd. Drugs for treating or preventing disorders of corneal and/or conjunctival epithelial cells
WO2004089381A1 (en) 2003-04-02 2004-10-21 Nexmed (Holdings), Inc. Prostaglandin compositions and their use for the treatment of vasospasm
DK1853271T3 (da) * 2005-03-04 2011-01-24 Sucampo Ag Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme
KR20140147142A (ko) 2006-01-24 2014-12-29 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
US8513441B2 (en) * 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
CA2750487A1 (en) * 2009-01-22 2010-07-29 Apotex Pharmachem Inc. Methods of making lubiprostone and intermediates thereof
US8609729B2 (en) * 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
MX342511B (es) 2011-04-07 2016-10-03 Nexmed Holdings Inc Metodos y composiciones para tratar la enfermedad de raynaud.
JP6957610B2 (ja) 2016-10-06 2021-11-02 スキャンポ・アーゲーＳｕｃａｍｐｏ ＡＧ 医薬品用途のための多層ビーズ

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740953A1 (de) * 1977-09-12 1979-03-22 Thera Ges Fuer Patente Verwendung von prostaglandinen zur senkung des blutzuckerspiegels
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
US5166174A (en) * 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
DE3869471D1 (de) * 1987-05-15 1992-04-30 Ueno Seiyaku Oyo Kenkyujo Kk Fiebersteigende zusammensetzung.
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.

Also Published As

Publication number Publication date
ATE141794T1 (de) 1996-09-15
JPH0570354A (ja) 1993-03-23
EP0503887B1 (en) 1996-08-28
NZ241940A (en) 1997-07-27
CA2062653C (en) 2002-08-20
EP0503887A3 (en) 1993-01-13
AU648877B2 (en) 1994-05-05
KR920017655A (ko) 1992-10-21
US5252605A (en) 1993-10-12
DE69213057T2 (de) 1997-01-09
AU1286192A (en) 1992-09-17
DE69213057D1 (de) 1996-10-02
CA2062653A1 (en) 1992-09-15
EP0503887A2 (en) 1992-09-16
DK0503887T3 (da) 1996-09-16
GR3021117T3 (en) 1996-12-31
KR100221370B1 (ko) 1999-09-15
JP2515458B2 (ja) 1996-07-10

Similar Documents

Publication Publication Date Title
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ATE69376T1 (de) Haarwuchsmittel.
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
DE68912758D1 (de) Wundheilung.
GR3020902T3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
FI881862A7 (fi) Ortopedinen sidos.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
ES2019634B3 (es) Terapia con clorfeniramina.
SE8802040D0 (sv) New use
NO893346L (no) Saarheling.
ATE100715T1 (de) Wundheilung.
ATE99962T1 (de) Wundverband.
ES1004874Y (es) Vendaje terapeutico mejorado.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 503887

Country of ref document: ES